Takara Bio Inc.
Takara Bio Inc. (4974) is a leading biotechnology company based in Japan, specializing in the development and manufacturing of innovative products and services for the life sciences sector. The company operates primarily in the areas of genetic engineering, gene therapy, and regenerative medicine, providing a range of solutions including reagents, instruments, and services for genomic research, as well as cell and gene therapies. Takara Bio's core products include a variety of molecular biology reagents, CRISPR/Cas9 gene-editing tools, and other biotechnological innovations aimed at advancing research and development in genetics and biotechnology.